Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Par Drugs IPO is a fixed price issue of Rs 8.53 crores. The issue is entirely a fresh issue of 16.72 lakh shares.
Par Drugs IPO bidding started from May 3, 2019 and ended on May 8, 2019. The allotment for Par Drugs IPO was finalized on Monday, May 13, 2019. The shares got listed on NSE SME on May 16, 2019.
Par Drugs IPO price is ₹51 per share. The minimum lot size for an application is 2000 Shares. The minimum amount of investment required by retail investors is ₹102,000.
Pantomath Capital Advisors Pvt Ltd is the book running lead manager of the Par Drugs IPO, while Link Intime India Private Ltd is the registrar for the issue.
Refer to Par Drugs IPO RHP for detailed information.
| IPO Date | May 3, 2019 to May 8, 2019 |
| Listing Date | May 16, 2019 |
| Face Value | ₹10 per share |
| Price | ₹51 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 1,672,000 shares (aggregating up to ₹8.53 Cr) |
| Fresh Issue | 1,672,000 shares (aggregating up to ₹[.] Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 4,480,318 |
| Share holding post issue | 6,152,318 |
| Market Maker portion | 84,000 shares |
Par Drugs IPO offers 1,642,000 shares. 778,000 (47.38%) to NII, 780,000 (47.50%) to RII, 30,000 (1.83%) to employees.
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor Shares Offered | - |
| Market Maker Shares Offered | 84,000 (5.12%) |
| Other Shares Offered | 778,000 (47.38%) |
| Retail Shares Offered | 780,000 (47.50%) |
| Employee Shares Offered | 30,000 (1.83%) |
| Total Shares Offered | 1,642,000 (100%) |
Par Drugs IPO opens on May 3, 2019, and closes on May 8, 2019.
| IPO Open Date | Friday, May 3, 2019 |
| IPO Close Date | Wednesday, May 8, 2019 |
| Basis of Allotment | Monday, May 13, 2019 |
| Initiation of Refunds | Tuesday, May 14, 2019 |
| Credit of Shares to Demat | Wednesday, May 15, 2019 |
| Listing Date | Thursday, May 16, 2019 |
| Cut-off time for UPI mandate confirmation | 5 PM on May 8, 2019 |
Investors can bid for a minimum of 2000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹102,000 |
| Retail (Max) | 1 | 2000 | ₹102,000 |
| Lot Size Calculator | |||
Falgun Vallabhbhai Savani and Jignesh Vallabhbhai Savani are the promoters of the company.
| Share Holding Pre Issue | 99.55% |
| Share Holding Post Issue | 72.82 |
Incorporated in 1999, Gujarat based Par Drugs and Chemicals Limited is engaged in the business of manufacturing and developing active pharma ingredients (API) for the Indian and international markets. APIs are used as the main ingredient in making tablets, capsules, and other finished dosages. The company also produces various antacid molecules.
It has two manufacturing facilities located at Ankleshwar and Bhavnagar in Gujarat. Currently, the company has a total of 6 Fine Chemical and 12 API products which are available in the market of 17 countries, including India. Some of the customers of the company are Dabur India Ltd, Meyer Organics Pvt. Ltd, Cadila Healthcare Ltd., Cipla Ltd, and Pfizer Ltd. For fiscal 2018, the international and domestic operations recorded 86.88% and 13.12%, respectively from the total company sales.
The company has a testing laboratory to maintain quality standards for finished products and raw materials. Par Drugs and Chemicals Ltd also performs drying operations of the products provided by customers in the liquid form and converts them into powders.
The competitive strengths of the company are:
1. Diversified product range
2. International presence
3. Prompt sales & distribution network
4. A good track record
5. Strong chemistry capabilities
| Particulars | For the year/period ended (in Rs. Lakhs) | ||||
|---|---|---|---|---|---|
| 31-Mar-19 | 31-Mar-18 | 31-Mar-17 | 31-Mar-16 | ||
| Total Assets | 5,135.55 | 5,393.89 | 5,604.14 | 5,803.08 | |
| Total Revenue | 4,641.20 | 4,241.65 | 4,880.90 | 3,326.43 | |
| Profit After Tax | 241.88 | 149.53 | 184.78 | 42.18 | |
The Net Proceeds from Issue towards the following objects:
1. Funding the working capital requirements of the Company; and
2. General corporate purposes.
[Dilip Davda] Investors may consider investment for the long term. Based on financial parameters (including P/BV data) issue appears reasonably priced. Promoters have converted shares at Rs. 66 while the issue is priced lower. Employees too are offered shares at the same price of IPO. Read detail review...
The Par Drugs IPO is subscribed 5.74 times on May 8, 2019 5:00:00 PM. The public issue subscribed 7.97 times in the retail category, times in the QIB category, and 3.48 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| Other | 3.48 |
| Retail | 7.97 |
| Employee | 1.00 |
| Total | 5.74 |
| Listing Date | May 16, 2019 |
| BSE Script Code | |
| NSE Symbol | PAR |
| ISIN | INE04LG01015 |
| Final Issue Price | ₹51 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| NSE SME |
|---|
| ₹51.00 |
| ₹52.90 |
| ₹50.30 |
| ₹52.90 |
| ₹50.45 |
Par Drugs and Chemicals Limited
805, Dwarkesh Complex,
R.C. Dutt Road,
Alkapuri, Vadodara-390 007,
Phone: +91 265 2332018
Email: cs.sanket@pardrugs.com
Website: http://pardrugs.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: pardrugs.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
SME Company Owners
We could help you get listed on the stock market.
Check our SME IPO Guide 
Par Drugs IPO is a SME IPO of 1,672,000 equity shares of the face value of ₹10 aggregating up to ₹8.53 Crores. The issue is priced at ₹51 per share. The minimum order quantity is 2000 Shares.
The IPO opens on May 3, 2019, and closes on May 8, 2019.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
The Par Drugs IPO opens on May 3, 2019 and closes on May 8, 2019.
Par Drugs IPO lot size is 2000 Shares, and the minimum amount required is ₹102,000.
You can apply in Par Drugs IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Par Drugs IPO will be done on Monday, May 13, 2019, and the allotted shares will be credited to your demat account by Wednesday, May 15, 2019. Check the Par Drugs IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
IPO Guru (2500+ Posts, 5400+ Likes)
IPO Mentor (700+ Posts, 400+ Likes)
Top Contributor (200+ Posts, 200+ Likes)
